Additional TB Resources

The Pediatric Assembly of the American Thoaracic Society (ATS) sponsored this webinar as part of its Virtual International Pediatric Pulmonary Network clinical case series. The first case was presented and discussed by Tony Onyia, MD, University of Nigeria Teaching Hospital, Dept of Pediatrics, Ituku-Ozalla Enugu Nigeria. The second case was presented by Birce Sunman, MD, Gülhane Training and Research Hospital, Ankara and discussed by Prof Hasan Yüksel, Celal Bayar University, School of Medicine, Dept of Pediatric Pulmology, Manisa and Assoc. Prof. Zafer Dökümcü, Ege University, School of Medicine, Dept of Pediatric Surgery, Izmir, Türkiye. The session is chaired by Prof. Joy Eze, University of Nigeria Teaching Hospital, Dept. Of Pediatrics, Ituku-Ozalla Enugu Nigeria and Prof. Özge Yılmaz from Manisa Celal Bayar University, School of Medicine, Dept. Of Pediatric Allergy, Manisa, Türkiye.

Submission Status: OPEN Submission Deadline: ONGOING Journal of Clinical Microbiology® (JCM) welcomes contributions to a Special Series on Diagnostic Testing for Mycobacteria. Tuberculosis is currently the world’s top infectious killer, and non-tuberculous mycobacteria (NTM) infections are also on the rise. Mycobacterial infections are more common in low-income nations and in patients with chronic health conditions. Accessible and accurate diagnosis of these infections is needed to guide effective treatment in these vulnerable patients. What We’re Looking for We welcome studies about the following: Inexpensive and accurate tests for tuberculosis, particularly tests that reduce the barriers of sputum-based diagnostics. Novel whole genome sequencing approaches to improve care of patients with tuberculosis through prediction of antimicrobial susceptibility and to improve rapid investigation of the spread of M. tuberculosis. Novel methods for rapid diagnostic testing for non-tuberculosis mycobacteria and for detection of antimicrobial resistance in mycobacteria (including non-tuberculosis and rapid-growing mycobacteria). Improved and novel diagnostics, including non-invasive tests, for extra-pulmonary tuberculosis. Suggested article types: Full-Length Text* New-Data Letter* Minireview** Commentary**

This CDC resource provides up-to-date surveillance data and statistics on tuberculosis (TB) in the United States.

A library of resources for the prevention, management, and elimination of TB.

Mantoux Tuberculin Skin Test Video

CDC has developed multiple tools for use in management and analysis of data collected during TB contact, cluster, and outbreak investigations.

The Translating Research into Practice (TRiP) Workgroup was formed in 2006 by the Tuberculosis Epidemiologic Studies Consortium (TBESC) to promote application and dissemination of TBESC research findings to field and public health practice. This website gives public health partners access to select tools and products from TBESC studies.

Professional Resources & Tools from Centers for Disease Control and Prevention (CDC)

This CDC website provides comprehensive information on TB, including symptoms, testing, treatment, prevention, and resources for healthcare providers, public health professionals, and the general public.

This insightful CFAR seminar, presented by Dr. Richard Chaisson, tackles the critical question: is global tuberculosis elimination a realistic goal or an overly ambitious dream? Drawing on data and clinical experience, he examines key challenges in TB control—such as diagnostics, treatment access, and systemic barriers—while highlighting strategic priorities for meaningful progress. A must-watch for those working in TB, HIV, and public health.

This podcast features Dr. Valwynne Faulkner, a postdoctoral researcher at the Francis Crick Institute and a LifeArc Knowledge Transfer Innovations Fellow. Her work bridges cutting-edge molecular biology and technology transfer. In this episode, she discusses her team's innovative use of CRISPR to uncover new strategies for tackling tuberculosis — including drug-resistant strains.

This document provides criteria for each diagnosis and a coding scheme for each diagnoses including levels of evidence confirmed, probable and no distinction between confirmed and probable.

“Defeating Tuberculosis: An Adventure with Learning” is an educational booklet designed for children, presenting essential information about tuberculosis in a playful and interactive way. This English version was adapted from the original publication in Portuguese. The material introduces basic concepts of microbiology, highlighting the differences between viruses, bacteria, and fungi, and teaches key prevention measures such as vaccination and the importance of hygiene. Through interactive activities — including games, coloring pages, and challenges — the booklet encourages children to learn about TB symptoms, the importance of early diagnosis, and the role of health professionals in treatment. At the end, children receive a “Little Health Scientist Certificate”, reinforcing the message that everyone can contribute to the prevention and elimination of tuberculosis.

This report provides an overview of the latest tuberculosis (TB) epidemiological situation and is published jointly by the WHO Regional Office for ECDC.

Functional Assessment of Chronic Illness Therapy - Tuberculosis (FACIT-TB): For patients with tuberculosis. This validated questionnaire can be used with person with active TB to assess both physical and mental well being in a clincal or resarch setting. It is available in Arabic English, Indonesian, Sinhala, Tagalog, and Urdu.

This video features a conversation with Dr. Atul Gawande, former USAID Global Health Assistant Administrator, on the future of global health. It offers an accessible and impactful overview of tuberculosis—the world’s leading infectious disease killer. The discussion covers key global TB statistics, challenges in diagnosis and treatment—particularly in low-resource settings—and the urgent need for sustained political commitment and funding. Featuring insights from global health leaders and individuals affected by TB, the video underscores why TB remains a pressing public health challenge and outlines priorities for moving toward its elimination.

Heartland National Tuberculosis Center offers education, training, research support, and program development resources for healthcare professionals and public health providers. Please explore the website for more details.

Heartland National Tuberculosis Center training archives feature past trainings covering diagnostics, treatment, prevention, and comorbidities, aimed at expanding individuals' knowledge and skills in tuberculosis care.

The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS Clinical Trials Networks of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. This website offers essential resources, including SOPs, webinars, and training modules, providing tools and guidance to enhance scientific literacy, community engagement, and effective research practices in HIV/AIDS and TB.

The 4th Virtual Roadshow focused on public-private TB care service delivery models, hosted by the TBPPM Learning Network India Chapter, which brings together experts to discuss innovative TB-PPM models, private sector engagement strategies, and key insights from STOP TB projects.

Lecture by Dr. Tess Ryckman.

Podcast- Why TB, an ancient health threat, remains a public health threat.

The Mayo Clinic Center for Tuberculosis offers education, training, research support, and program development resources for healthcare professionals and public health providers. Please explore the website for more details.

The Mayo Clinic Center for Tuberculosis webinar library features recorded sessions covering diagnostics, treatment, prevention, and comorbidities, aimed at expanding individuals' knowledge and skills in tuberculosis care.

This monthly webinar series offers healthcare professionals the latest insights in tuberculosis (TB). Tuberculosis experts will discuss screening, diagnosis, and treatment of TB disease and latent TB infection (LTBI). Topics include considerations for pediatric and adult populations, clinical updates, diagnostic methods, and treatment strategies. Healthcare professionals managing patients with TB can stay informed on research developments and emerging treatment regimens for active TB and LTBI, exploring innovative approaches to enhance patient adherence and outcomes.

This webinar explores mycobacterial diagnostic tools and their applications in TB prevention and treatment. Learn to effectively use and interpret Tuberculin Skin Tests (TSTs), interferon-gamma release assays (IGRAs), and cultures for diagnosing latent TB infection (LTBI) and active TB disease. Case studies will highlight real-world challenges and best practices for leveraging these tools in clinical practice.

Tuberculosis (TB) in pregnancy poses serious risks to both mother and fetus if not promptly diagnosed and managed. This webinar covers key aspects of TB diagnosis, treatment, and complications during pregnancy. Participants will also be introduced to the TB Pregnancy Toolkit and other resources to support effective care for pregnant patients.

McGill TBcentre - many webinars and mini courses (all prerecorded)

TSTin4D and IGRAin4D are both are decision aids providing information about the likelihood of developing TB disease, dying from TB, as well as post-TB disability, in the next 20 years in a person with a positive tuberculin skin test or a positive Interferon gamma release assay and a known risk factor. This also provides information on the potential benefits and risks of TB preventive therapy. Also added is information for the person considering whether to accept TB preventive therapy, including a handout that includes predictions for them, and some basic information about TB prevention.

Advancing TB research through open-access, multi-domain, global TB data and tools.

Join Partners In Health (PIH) for an inspiring conversation between Ophelia Dahl, PIH co-founder and chair of the board of directors, and John Green, PIH trustee and bestselling author. Together, they’ll discuss John’s journey with PIH to create change and save lives around the globe, specifically in maternal health and tuberculosis care, and the ways Ophelia and John both harness the power of community and storytelling to create a more just world.

A discussion including leading TB experts, authors, and thought leaders to shed light on how actions from the Trump administration affect patients and the long fight against TB.

Presented by Shibu Vijayan

This webinar, held as part of the INDO-US TB Programme, brings together leading experts to spotlight the critical research gaps that must be addressed to help India achieve its TB elimination goals by 2025. It covers key focus areas from diagnostics and treatment innovations to operational research and policy implementation strategies.

These 2 presentation are part of the RePORT International Global Research Forum. Presentation 1: Results of the RICC Survey on AI: Are we ready for the future? by Sanjana Gandikota, Masters of Global Public Health Student, Rutgers School of Public Health Presentaion 2: Making Scientific Publications More Accessible, Along with the ChatGPT Application by Dr. Mariana Araújo-Pereira, Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative

Presented by Bruno Andrade

Lecture by Farai Mavhunga, Unit Head for the Vulnerable Populations, Communities and Comorbidities (VCC) unit, WHO Global Tuberculosis Program, Geneva.

A lecture by Dr. Jennifer Furin from Harvard Medical School.

A lecutre by Dr. W.Evan Johnson from Rutgers University - New Jersey Medical School.

Presented by Prof. Friedrich Thienemann, University of Cape Town

An insightful presentation in which Dr. Redrigo Menezes of the University Center of Espirito Santo in Colatina, Brazil, explores the intersection of TB and planetary health. He examines how environmental factors, climate change, and ecosystem disruptions influence TB transmission and outcomes, highlighting the urgent need for integrated, systems-based approaches to address both human and environmental health challenges.

Presented by Chetan Gadgil

Presented by Umesh Shaligram

Presented by Karen Dobos

The Resist TB Webinar, including David Holtzman of the Gates Medical Research Institute, discussing the PANTB collaboration Phase 2B2C trial updates.

Organization which offers periodic webinars, and has a monthly newsletter with current publications on DR-TB.

A PDF of the RESIST-TB June 2025 MDR-TB article list with abstracts. This includes 70 articles and 2 recent TB news articles with links and descriptions.

Rutgers Global Tuberculosis Institute offers education, training, research support, and program development resources for healthcare professionals and public health providers. Please explore the website for more details.

Rutgers Global Tuberculosis Institute training archives feature past webinars covering diagnostics, treatment, prevention, and comorbidities, aimed at expanding individuals' knowledge and skills in tuberculosis care.

Rutgers Global Tuberculosis Institute webinar archives feature past webinars covering diagnostics, treatment, prevention, and comorbidities, aimed at expanding individuals' knowledge and skills in tuberculosis care.

Access the SEATRAC Advanced TB Training recordings for 2023 and 2024 through this link.This virtual program offered by the University of Washington's SEATRAC, which provides advanced, multidisciplinary training in TB research. It covers key domains such as immunology and vaccines, pathogenesis and treatment, diagnostics, transmission, disease modeling, implementation science, and advocacy, geared toward both emerging and experienced investigators engaging in TB research.

The Southeastern National Tuberculosis Center (SNTC) archived webinar library features recorded sessions covering diagnostics, treatment, prevention, and comorbidities, aimed at expanding individuals' knowledge and skills in tuberculosis care.

The Southeastern National Tuberculosis Center (SNTC) offers education, training, research support, and program development resources for healthcare professionals and public health providers. Please explore the website for more details.

Video in multiple languages for collecting sputum sample

Watch webinars, event recordings, and advocacy videos from the Stop TB Partnership.

A session from the 78th World Health Assembly focused on new financing models and emerging technologies in TB. Speakers emphasized sustainable investment and digital health tools to improve prevention, diagnosis, and treatment.

This session called for increased domestic TB funding in Africa, private sector engagement, and innovation in service delivery, governance, and regulation—underscoring community-driven and politically aligned strategies.

This three-part webinar series by the Stop TB Partnership and FIND provides an in-depth overview of targeted next-generation sequencing (tNGS) technology for detecting drug-resistant tuberculosis. The series covers fundamental principles of tNGS, its advantages over traditional diagnostic methods, and practical guidance on implementing tNGS in high-burden and resource-limited settings. Featuring expert insights and case studies, the webinars highlight early program experiences and discuss how tNGS supports WHO-endorsed strategies to improve rapid and comprehensive detection of TB drug resistance worldwide.

This website features TAG’s latest updates in the fight to end HIV/AIDS, Hepatitis C, and Tuberculosis. It includes the Pipeline Report on innovations in diagnosing, preventing, treating, and curing HIV, HCV, and TB; information on TB research funding; recorded webinars; advocacy letters and comments submitted or endorsed by TAG; and official press releases and statements.

Please refer to the link for the TAG's latest edition of TB Treatment Pipeline Report. The report provides the latest information on 22 new or repurposed drugs in clinical development for TB and summarizes ongoing, planned, and recently completed trials. Included in this year's report are: Results from the phase 3 endTB-Q trial and two phase 2b/c trials of quabodepistat-containing regimens completed or discontinued in 2024; First-of-their-kind trials focused on asymptomatic TB and bedaquiline-resistant TB; The first long-acting formulation of a TB drug to enter clinical development; and The first phase 3 trial of a new drug from a new class since bedaquiline and delamanid.

The new 2025 update of An Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis lays out what community advocates need to know about WHO-recommended regimens for drug-resistant TB. The Activist Guide reviews the evidence-base behind these regimens, important considerations for key populations affected by TB, the access landscape, and more. The publication is intended to equip advocates with information they need to formulate arguments and push for universal implementation of the best available treatments.

TAG’s Cheat Sheets for Tuberculosis Activists are designed to help advocates navigate the range of tools in use and in the research pipeline.

To accompany the updated Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis, TAG also developed three additional educational materials to support community-based and civil society organizations leading treatment literacy, peer support, and community-led monitoring activities:

The World Health Organization (WHO) guidelines for diagnosing TB have evolved along with available technologies and tools that are increasingly accurate, simple, and efficient at detecting TB and resistance to a wider range of TB drugs. Despite this progress, 2.7 million individuals with TB still remain undiagnosed and undetected. On July 17th, 2025, TAG hosted a community webinar on tests for TB and drug resistance. The webinar breaks down the latest WHO guidelines and explores the most effective tools for diagnosing TB and drug resistance. The webinar also launched TAG’s updated resource, An Activist’s Guide to Diagnostic Tools for Tuberculosis, and provides a deep dive into two sections of the Guide: (1) the array of WHO-recommended diagnostic tools and how they should be optimally used in country programs; and (2) key access considerations and actions activists can take to ensure that all people at risk of TB receive quality TB diagnostic testing.

The Tuberculosis Data, Impact Assessment and Communications Hub (TB DIAH) supports decision-makers by generating, analyzing, and utilizing quality data to inform and scale up effective TB services. This website provides resources on TB M&E and surveillance processes.

Treatment Action Group (TAG) and the Community Research Advisors Group (CRAG) released the TB Representative Studies Rubric (TB RSR), a new tool that community advisory boards (CABs) can use when designing and reviewing clinical trials protocols. The TB RSR is a 17-item questionnaire that assesses whether TB treatment trials include the types of people who get TB. By documenting the representativeness of TB studies, community advisors and researchers can work together to ensure that all people in need of safe and effective options for treating and preventing TB can benefit from research.

A three-part online study club series, hosted by the Diagnostics Equity Consortium (DEC) and the Global TB Community Advisory Board (TB CAB), explores the evolving TB diagnostic landscape and strategies to expand testing coverage. Session one addresses the TB testing gap and emerging diagnostic tools. Session two focuses on optimizing national diagnostic networks and test distribution. Session three examines the impact and trade-offs of near- and point-of-care TB tests in expanding access.

This Crash Course video, The Deadliest Infectious Disease of All Time, explores the history, biology, and global impact of TB. From its ancient origins to its ongoing role as a leading cause of infectious death worldwide, the video examines how TB spreads, why it remains so deadly, and how social and political factors shape its burden. Engaging and informative, the episode highlights both scientific advances and enduring health inequities.

The 2025 Results Report is a snapshot of the partnerships' progress in the fight to end AIDS, TB and malaria during 2024.

The PHA Editors will consider any manuscript reporting original research on progress to achieving the SDGs. Suitable topics include infection-related topics such as vaccines, infection prevention control, outbreaks and antimicrobial resistance. Non-communicable diseases of public health importance include nutrition, the impact of climate change and planetary health. The journal aims to improve public health practice and we welcome operational research, lessons from implementation and evaluations of public health interventions. We will also consider submissions that focus on issues related to health care access and universal health coverage, quality, efficiency, cost-effectiveness, ethics and equity as well as education and training.

The Union has three official journals: >> The International Journal of Tuberculosis and Lung Disease, IJTLD - the leading peer-reviewed journal dedicated to lung health worldwide. >> IJTLD Open - The Union's new Open Access journal for the latest research on TB and lung diseases including asthma, COVID-19 and COPD. >> Public Health Action - the latest operational research on health systems.

This webinar recording explores mycobacterial diagnostic tools and their applications in TB prevention and treatment. Learn to effectively use and interpret TSTs, IGRAs, and cultures for diagnosing LTBI and active TB disease. Case studies will highlight real-world challenges and best practices for leveraging these tools in clinical practice.

TB in pregnancy poses serious risks to both mother and fetus if not promptly diagnosed and managed. This webinar recirding covers key aspects of TB diagnosis, treatment, and complications during pregnancy. Participants will also be introduced to the TB Pregnancy Toolkit and other resources to support effective care for pregnant patients.

University of California San Francisco (UCSF) Center for Tuberculosis offers education, training, research support, and program development resources for healthcare professionals and public health providers. Please explore the website for more details.

This is an archived collection of past webinars from the UCSF Curry International TB Center. Recordings and materials are available for reference and continued learning for researchers and clinicians.

A free educational tool for healthcare providers treating pediatric TB. Updated in May 2025, it includes a five-part video series (64 minutes) by Dr. Ann M. Loeffler and downloadable clinical tools and handouts.

This 3-session webinar series highlight lectures from The Union-North American Region (NAR) 2025 Annual TB Conference. This webinar includes 1. The Riddle of TB Drug Resistance, 2. What is Hot in Treatment Differentiation and Individualization and 3. Reframing Directly Observed Treatment.

The UCSF Curry International TB Center offers free training opportunities for healthcare and public health professionals involved in TB prevention and care. Core trainings cover key topics such as case management, contact investigation, LTBI, clinical care, and program management, and are available in both hybrid and in-person formats. All trainings are free of charge, but registration and application are required. For further questions, please contact: CurryTBCenter@ucsf.edu.

This webinar covered Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in persons with TB and how to medically manage these patients.

This website provides access to the latest WHO recommendations on all aspects of tuberculosis prevention and care. The user can search, filter and cross-tabulate the recommendations through built-in functions. For each individual recommendation one can also access key background information, such as the evidence summaries and the Guideline Development Group decisions underpinning it.

This call to action accompanies the consensus statement on the optimal and early inclusion of pregnant and lactating women in tuberculosis research and specifies the actions that need to be taken to ensure full implementation of the agreed approaches in the statement. The target audience includes product developers and industry, study sponsors, funding agencies, researchers and research networks, regulatory authorities, institutional review boards (IRBs) and ethics committees, national TB and maternal and child health programmes, civil society organizations and affected communities, and health care providers.

In 2024, the WHO Global Programme on Tuberculosis & Lung Health led a consensus building process to advance the earlier and optimal inclusion of pregnant women in TB research. The process is aligned with broader global developments to transform clinical trial practices, including addressing the needs of underrepresented populations. This consensus statement summarizes the consensus process, which included five thematic working groups (covering preclinical TB research, TB therapeutics research, TB vaccine research, maternal TB surveillance systems and advocacy), evidence reviews to address gaps in data and knowledge and a consensus meeting in February 2025. The approaches to earlier and optimal inclusion arising from the consensus process include crosscutting actions as well as approaches specific to each working group theme.

The WHO TB Patient Cost Survey resources include a standardized household questionnaire (2025 version) for collecting data on the economic impact of TB, along with companion STATA datasets and code to support data entry, management, and analysis. These tools are designed to promote consistent methodology and facilitate cross-country comparisons in TB research and program evaluation.

The WHO TB Patient Cost Survey resources include a standardized household questionnaire (2025 version) for collecting data on the economic impact of TB, along with companion STATA datasets and code to support data entry, management, and analysis. These tools are designed to promote consistent methodology and facilitate cross-country comparisons in TB research and program evaluation.

The new WHO TPPs for TB screening tests were developed after an extensive consultation of a large cross section of constituencies. They provide manufacturers and other stakeholders in research and development with the latest product- and technology-agnostic guidance that encompass all possible approaches used for TB screening.

The “WHO operational handbook on tuberculosis. Module 3: diagnosis” provides an implementation guidance on detection of TB infection, disease and drug resistance within a single reference document. It also provides updates to the diagnostic algorithms, in view of new recommendations on concurrent testing of respiratory and non-respiratory samples among adults and adolescents with HIV, children with HIV, and children without HIV or with unknown HIV status. Finally, it summarizes updates on diagnostic accuracy of the WHO recommended technologies, in view of the WHO TB Diagnostic guidelines updates as well as analysis of discordant results. This document accompanies the “WHO consolidated guidelines on tuberculosis. Module 3: diagnosis”, which summarizes and updates the latest WHO recommendations on the detection of TB infection, disease, and drug resistance for Member States, technical partners, and other stakeholders.

Database for WHO publications

Can access all WHO TB guidelines, operational handbooks and training material together in one place

This app allows users to explore and interact with data from the WHO 2024 Global Tuberculosis Report. It is also available on the Apple App Store by searching for 'TB Report'.

This website provides access to the WHO Global Programme on Tuberculosis and Lung Health's series of TB-related reports dating back to 1997. These reports offer valuable insights into global TB trends, epidemiology, and progress toward TB elimination.

Developed by WHO “The purpose of the manual is to provide guidelines and supporting material for sites embarking on STEPS chronic disease risk factor surveillance.” While focus is non-communicable diseases useful information for communicable disease e.g., STEPS instrument.

The TB digital platform offers dashboards displaying global TB data—from overall trends to specific sources like prevalence surveys. It brings together data from all countries and makes it easier to access and understand through clear, user-friendly visuals.

The database provides the most up-to-date information on clinical trials, operational research, and other studies related to TB and MDR-TB.

The WHO Global Tuberculosis Programme's newsletter for World TB Day 2025, which highlights the theme "Yes! We Can End TB: Commit. Invest. Deliver." The newsletter calls for urgent action to turn global commitments into results, increase funding, and scale up interventions that are proven to be effective, especially for drug-resistant TB. It includes key messages from various global leaders, such as the WHO Director-General, Dr. Tedros, and author John Green, highlighting the need for solidarity and sustained momentum to end TB